Marc Samuels Speaks at the American Society of Gene and Cell Therapy Policy Summit

on September 23, 2024 // 4:10-5:00pm EST

Join Marc Samuels, CEO and President of ADVI Health, at the American Society of Gene and Cell Therapy Policy Summit on Monday, September 23, 2024, for the 2025 Payment Policy Look-Ahead Panel.

As the landscape of payment policies for cell and gene therapies evolves, understanding its impact on access has never been more important. Marc will share his expertise on value-based arrangements, coverage, and access under employer-sponsored plans and discuss the challenges of prior authorization. He’ll also provide the latest insights on the current political landscape and what to expect in the realm of payment policy updates for 2025. Don’t miss this opportunity to gain valuable knowledge from a leading voice in healthcare policy, alongside a dynamic group of expert panelists:

  • Marc Samuels, JD, ADVI Health
  • Pam Traxel, American Cancer Society Cancer Action Network
  • Benjamin Rome, MD, Brigham and Women’s Hospital
  • Brian Miller, MD, Johns Hopkins University School of Medicine
  • Moderator: Zachary Brennan, Endpoints News

Get in touch to meet with Marc and #ADVIExpert Alicia Silver, director, market access, cell and gene therapy while you are at the event.

ADVI Team

Marc Samuels

CEO and President

Alicia Silver

Director

Further Resources:

ADVI insights

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Instant: CMS Issues MFPs for the First 10 Drugs Selected for Government Negotiation

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Instant: CMS Releases Final Part Two Guidance for the MPPP Program

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Instant: CMS Releases the FY 2025 IPPS Final Rule

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Instant: CMS Releases 2025 OPPS Proposed Rule